SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-12-467494
Filing Date
2012-11-13
Accepted
2012-11-13 16:31:15
Documents
12
Period of Report
2012-09-30

Document Format Files

Seq Description Document Type Size
1 FROM 10-Q d398663d10q.htm 10-Q 396028
2 EX-10.1 d398663dex101.htm EX-10.1 20700
3 EX-31.1 d398663dex311.htm EX-31.1 5732
4 EX-31.2 d398663dex312.htm EX-31.2 5723
5 EX-32.1 d398663dex321.htm EX-32.1 4084
6 EX-32.2 d398663dex322.htm EX-32.2 4044
  Complete submission text file 0001193125-12-467494.txt   3223011

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT ccxi-20120930.xml EX-101.INS 457448
8 XBRL TAXONOMY EXTENSION SCHEMA ccxi-20120930.xsd EX-101.SCH 25184
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ccxi-20120930_cal.xml EX-101.CAL 38406
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ccxi-20120930_def.xml EX-101.DEF 125449
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE ccxi-20120930_lab.xml EX-101.LAB 237080
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ccxi-20120930_pre.xml EX-101.PRE 175503
Mailing Address 850 MAUDE AVENUE MOUNTAIN VIEW CA 94043
Business Address 850 MAUDE AVENUE MOUNTAIN VIEW CA 94043 650-210-2900
ChemoCentryx, Inc. (Filer) CIK: 0001340652 (see all company filings)

IRS No.: 943254365 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35420 | Film No.: 121199145
SIC: 2834 Pharmaceutical Preparations